These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29907277)

  • 1. Complications of Durable Left Ventricular Assist Device Therapy.
    Emani S
    Crit Care Clin; 2018 Jul; 34(3):465-477. PubMed ID: 29907277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unforeseen consequences of therapy with continuous-flow pumps.
    Frazier OH
    Circ Heart Fail; 2010 Nov; 3(6):647-9. PubMed ID: 21081738
    [No Abstract]   [Full Text] [Related]  

  • 3. Implication of Hemodynamic Assessment during Durable Left Ventricular Assist Device Support.
    Imamura T; Narang N
    Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32824131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Left Ventricular Assist Devices.
    Aissaoui N; Jouan J; Gourjault M; Diebold B; Ortuno S; Hamdan A; Latremouille C; Pirracchio R; Morshuis M
    Blood Purif; 2018; 46(4):292-300. PubMed ID: 30048974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device Management and Flow Optimization on Left Ventricular Assist Device Support.
    Tchoukina I; Smallfield MC; Shah KB
    Crit Care Clin; 2018 Jul; 34(3):453-463. PubMed ID: 29907276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic valve opening and thrombotic events with continuous-flow left ventricular assist devices.
    Saeed O; Maybaum S; Alessandro DD; Goldstein DJ; Patel SR
    J Heart Lung Transplant; 2014 Jan; 33(1):109-12. PubMed ID: 23937883
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of adverse events on ventricular assist device outcomes.
    Adzic A; Patel SR; Maybaum S
    Curr Heart Fail Rep; 2013 Mar; 10(1):89-100. PubMed ID: 23314865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired von Willebrand syndrome associated with left ventricular assist device.
    Nascimbene A; Neelamegham S; Frazier OH; Moake JL; Dong JF
    Blood; 2016 Jun; 127(25):3133-41. PubMed ID: 27143258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.
    McKellar SH; Deo S; Daly RC; Durham LA; Joyce LD; Stulak JM; Park SJ
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):344-8. PubMed ID: 23246052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
    Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
    J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
    Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial infarction after left ventricular assist device implantation: clinical course, role of aortic root thrombus, and outcomes.
    Fried J; Han J; Naka Y; Jorde UP; Uriel N
    J Heart Lung Transplant; 2014 Jan; 33(1):112-5. PubMed ID: 24418737
    [No Abstract]   [Full Text] [Related]  

  • 15. Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device.
    Han J; Takeda K; Takayama H; Kurlansky PA; Mauro CM; Colombo PC; Yuzefpolskaya M; Fukuhara S; Truby LK; Topkara VK; Garan AR; Mancini DM; Naka Y
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):520-7.e1. PubMed ID: 26806510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device.
    Dobarro D; Urban M; Booth K; Wrightson N; Castrodeza J; Jungschleger J; Robinson-Smith N; Woods A; Parry G; Schueler S; MacGowan GA
    J Heart Lung Transplant; 2017 Jan; 36(1):42-49. PubMed ID: 27776988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of pump thrombosis in patients with left ventricular assist devices.
    Stulak JM; Sharma S; Maltais S
    Am J Cardiovasc Drugs; 2015 Apr; 15(2):89-94. PubMed ID: 25567787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of acquired von Willebrand syndrome during short-term micro axial pump support: implications for bleeding in a patient bridged to a long-term continuous-flow left ventricular assist device.
    Davis ME; Haglund NA; Tricarico NM; Keebler ME; Maltais S
    ASAIO J; 2014; 60(3):355-7. PubMed ID: 24614358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.